Cargando…
Signals were broadly positive for months, but never definitive: the tocilizumab story
BACKGROUND: Most treatment guidelines for coronavirus disease 2019 (COVID-19) currently recommend tocilizumab in combination with dexamethasone in critically ill patients who are exhibiting rapid respiratory decompensation. AIMS: To produce a critical review and summary of the pathway which led to t...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576060/ https://www.ncbi.nlm.nih.gov/pubmed/34768021 http://dx.doi.org/10.1016/j.cmi.2021.10.018 |